検索
10X Genomics Inc
TXGウォッチリストに追加
48.400USD
+0.340+0.71%
終値 07-23 16:00（ET）15分遅れの株価
6.18B時価総額
損失額直近12ヶ月PER
詳細情報 10X Genomics Inc 企業名
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
10X Genomics Incの企業情報
企業コードTXG
会社名10X Genomics Inc
上場日Sep 12, 2019
最高経営責任者「CEO」Saxonov (Serge Wilson)
従業員数1306
証券種類Ordinary Share
決算期末Sep 12
本社所在地6230 Stoneridge Mall Road
都市PLEASANTON
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号94588
電話番号19254017300
ウェブサイトhttps://www.10xgenomics.com/
企業コードTXG
上場日Sep 12, 2019
最高経営責任者「CEO」Saxonov (Serge Wilson)
10X Genomics Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.10M
-2.72%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
378.44K
+2.33%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+22.53%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
105.23K
-11.02%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
68.28K
+12.93%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
37.45K
+23.58%
Dr. Shehnaaz Suliman, M.D.
Dr. Shehnaaz Suliman, M.D.
Independent Director
Independent Director
31.72K
+9.79%
Mr. Alan V. Mateo
Mr. Alan V. Mateo
Independent Director
Independent Director
--
--
Dr. Sarah A. Teichmann
Dr. Sarah A. Teichmann
Independent Director
Independent Director
--
--
Mr. Adam S. Taich
Mr. Adam S. Taich
Chief Financial Officer
Chief Financial Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.10M
-2.72%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
378.44K
+2.33%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+22.53%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
105.23K
-11.02%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
68.28K
+12.93%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
37.45K
+23.58%
よくある質問
10X Genomics Incの上位5名の株主は誰ですか？
10X Genomics Incの上位5名の株主は以下のとおりです。Mr. Serge Wilson Saxonov, Ph.D.
10X Genomics Inc（TXG）の株式を保有している機関の数はいくつですか？
2026Q1時点で、10X Genomics Incの株式を保有している機関は726社あり、保有株式の総市場価値は約140.84Mで、全体の118.45%を占めています。2025Q4と比較して、機関の持ち株は-2946322.00増加しています。
10X Genomics Incの最大の収益源は何ですか？
2026Q1において、Consumables部門が10X Genomics Incにとって最大の収益を生み出しており、その金額は507.18Mで、全収益の78.90%を占めています。